The influence of cardiac and pulmonary comorbidities on overall survival (OS) among stage III non-small cell lung cancer (NSCLC) patients treated with definitive radiotherapy (RT)

被引：0
|
作者：
Correa, C. R. [1 ]
Wang, L. [1 ]
Zhao, L. [1 ]
Hayman, J. [1 ]
Kalemkerian, G. [1 ]
Cease, K. [1 ]
Brenner, D. [1 ]
Kong, F. M. [1 ]
机构：
[1] Univ Michigan, Med Ctr, Ann Arbor, MI USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2008.06.1349
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S428 / S429
页数：2
相关论文
共 50 条
  • [1] Comprehensive Analysis of Dosimetric Predictors of Overall Survival for Stage III Non-Small Cell Lung Cancer (NSCLC) Treated With Definitive Radiation Therapy
    Speirs, C. K.
    Rehman, S.
    Molotievschi, A.
    Velez, M. A.
    DeWees, T. A.
    Mullen, D.
    Fergus, S.
    Bradley, J. D.
    Robinson, C. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S667 - S667
  • [2] RADIOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC)
    De Ruysscher, D.
    LUNG CANCER, 2009, 64 : S21 - S21
  • [3] Incidence of central nervous system metastases (mCNS) and overall survival (OS) in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive chemoradiation followed by durvalumab (Durva)
    Sharp, John
    Zhao, Songzhu
    Patel, Sandip
    Wei, Lai
    Li, Mingjia
    Brownstein, Jeremy
    Welliver, Meng Xu
    Haglund, Karl
    Palmer, Joshua David
    Beyer, Sasha
    Raval, Raju R.
    Shields, Peter G.
    He, Kai
    Kaufman, Jacob
    Memmott, Regan Michelle
    Alahmadi, Asrar
    Carbone, David Paul
    Otterson, Gregory Alan
    Presley, Carolyn J.
    Owen, Dwight Hall
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Preoperative survivin, ERCC1, and PTEN expression in stage III non-small cell lung cancer (NSCLC) patients (pts) treated with neoadjuvant and definitive chemoradiation and association with overall survival (OS)
    Batus, Marta
    Fidler, Mary J.
    Walters, Kelly Kaiser
    Pool, Mark
    Mahon, Brett
    Basu, Sanjib
    Borgia, Jeffrey Allen
    Sher, David
    Bonomi, Philip D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Preoperative Survivin, Ercc1 And Pten Expression In Stage III Non-small Cell Lung Cancer (nsclc) Patients(pts) Treated With Neoadjuvant And Definitive Chemoradiation And Association With Overall Survival (os).
    Batus, M.
    Fidler, M.
    Walters, K. Kaiser
    Pool, M.
    Mahon, B.
    Basu, S.
    Borgia, J. A.
    Sher, D.
    Bonomi, P. D.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S238 - S238
  • [6] The impact of extent and location of mediastinal lymph node (LN) involvement on survival of stage III non-small cell lung cancer (NSCLC) patients treated with definitive radiotherapy
    Fernandes, Annemarie T.
    Faerber, Jennifer
    Lin, Lilie
    Evans, Tracey
    Stevenson, James
    Langer, Corey
    Eaby, Beth
    Kucharczuk, John
    Glatstein, Eli
    Hahn, Stephen
    Rengan, Ramesh
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S524 - S524
  • [7] Pretreatment Poor Pulmonary Function Is Prognostic Of Poor Overall Survival In Patients With Stage III Non-Small Cell Lung Cancer Treated With External Beam Radiotherapy
    Wei, X.
    Gomez, D.
    Zhuang, Y.
    Komaki, R.
    O'Reilly, M. S.
    Mohan, R.
    Liao, Z. X.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S270 - S270
  • [8] Influence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer Patients
    Lee, Joo Ho
    Wu, Hong-Gyun
    Kim, Hak Jae
    Kim, Dong-Wan
    Lee, Se-Hoon
    Kim, Tae Min
    Kim, Young Whan
    Heo, Dae Seog
    CANCER RESEARCH AND TREATMENT, 2012, 44 (04): : 242 - 250
  • [9] Definitive thoracic radiotherapy in oligometastatic stage IV non-small cell lung cancer (NSCLC).
    Fernandes, Annemarie Therese
    Xanthopoulos, Eric
    Handorf, Elizabeth
    Grover, Surbhi
    Sharma, Sonam
    Eaby-Sandy, Beth
    Evans, Tracey L.
    Stevenson, James
    Langer, Corey J.
    Mitra, Nandita
    Apisarnthanarax, Smith
    Lin, Lilie
    Rengan, Ramesh
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Polymorphisms in ERCC2 and overall survival (OS) in early stage non-small cell lung cancer (NSCLC).
    Suk, R
    Park, S
    Liu, G
    Cogan-Drew, T
    Zhou, W
    Su, L
    Lynch, T
    Wain, J
    Christiani, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 842S - 842S
12345